Reports for SANDOZ CANADA INCORPORATED

Company Name

SANDOZ CANADA INCORPORATED

Totals

Shortage reports

1850

Actual shortage: 47 (3%)
Anticipated shortage: 0 (0%)
Avoided shortage: 13 (1%)
Resolved: 1790 (97%)

Discontinuation Reports

82

To be discontinued: 1 (1%)
Discontinued: 79 (96%)
Reversed: 2 (2%)

Late reports

439 (23%)

Overdue reports

5 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SANDOZ ROSUVASTATIN 40MG TABLET Resolved 2019-10-15 2020-02-15 96500
SANDOZ ROSUVASTATIN 40MG TABLET Resolved 2020-01-21 2020-02-15 103846
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 1000UNIT SOLUTION Resolved 2022-11-28 2023-01-19 175989
SANDOZ CANDESARTAN 32MG TABLET Resolved 2022-12-28 2023-01-19 179495
SANDOZ FENTANYL PATCH 37MCG PATCH Resolved 2021-09-02 2021-09-09 145007
SANDOZ TELMISARTAN HCT 12.5MG 80MG TABLET Resolved 2022-12-28 2023-01-19 179524
SANDOZ OLANZAPINE 2.5MG TABLET Resolved 2021-11-03 2021-11-24 148764
ACETYLCYSTEINE SOLUTION 200MG SOLUTION Resolved 2023-12-11 2024-01-04 212999
SANDOZ ADAPALENE / BENZOYL PEROXIDE 2.5% 0.1% GEL Resolved 2023-05-01 2023-05-25 191366
SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE 2.5% 0.3% GEL Resolved 2024-02-05 2024-03-12 218447
SANDOZ ALENDRONATE 70MG TABLET Resolved 2022-10-12 2022-12-28 171540
SANDOZ ALENDRONATE 70MG TABLET Resolved 2023-04-04 2023-05-25 188633
SANDOZ ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-04-05 2022-05-10 157959
SANDOZ ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2022-11-16 2023-01-19 174953
SANDOZ ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2024-04-16 2024-05-14 225209
SANDOZ AMBRISENTAN TABLETS 5MG TABLET Resolved 2024-01-30 2024-04-24 217887
SANDOZ AMBRISENTAN TABLETS 10MG TABLET Resolved 2024-02-05 2024-04-24 218454
SANDOZ AMIODARONE 200MG TABLET Resolved 2020-07-24 2020-10-27 121064
AMIODARONE HYDROCHLORIDE FOR INJECTION 50MG LIQUID Resolved 2022-10-25 2023-03-29 172563
SANDOZ AMLODIPINE 10MG TABLET Resolved 2017-03-14 2017-06-26 2674

Showing 821 to 840 of 1850

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
FOLIC ACID INJECTION USP 5MG LIQUID To be discontinued 2019-05-01 2019-05-01 82956
FOLIC ACID INJECTION USP 5MG LIQUID Discontinued 2020-01-28 2020-01-28 104481
SANDOZ ALENDRONATE 10MG TABLET Discontinued 2019-11-19 2019-11-19 99259
ALFENTANIL INJECTION USP Discontinued 2019-10-15 2019-10-15 96610
ATRACURIUM BESYLATE INJECTION Discontinued 2019-10-15 2019-10-15 96613
SODIUM AUROTHIOMALATE INJECTION BP 50MG SOLUTION Discontinued 2018-07-13 2018-07-13 55768
BETAJECT Discontinued 2019-10-15 2019-10-15 96616
BLUE COLLYRIUM Discontinued 2019-10-15 2019-10-15 96619
BRETYLIUM TOSYLATE INJECTION USP 50MG SOLUTION Discontinued 2017-12-06 2017-12-06 31958
BRETYLIUM TOSYLATE INJECTION USP Discontinued 2020-04-01 2020-04-01 110288
CLINDAMYCIN INJECTION USP 150MG LIQUID Discontinued 2017-06-06 2017-10-18 12122
CODEINE PHOSPHATE INJECTION USP 30MG LIQUID Discontinued 2022-04-20 2022-04-20 159064
COMTAN 200MG TABLET Discontinued 2022-03-03 2022-03-04 155940
SANDOZ DILTIAZEM T Discontinued 2020-04-01 2020-04-01 110324
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Discontinued 2018-08-27 2019-01-02 59179
SANDOZ FINASTERIDE A 1MG TABLET Discontinued 2023-06-30 2023-07-01 196983
HEPARIN SODIUM INJECTION USP (SINGLE USE VIAL-PRESERVATIVE FREE) 10000UNIT SOLUTION Discontinued 2018-07-04 2018-07-31 54349
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2023-10-18 2023-10-19 207275
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) 10000UNIT SOLUTION Discontinued 2024-05-17 2024-05-18 228249
IMIPENEM AND CILASTATIN FOR INJECTION USP 250MG 250MG POWDER FOR SOLUTION Discontinued 2021-08-23 2021-08-23 144467

Showing 1 to 20 of 82